Correction to: Nature Medicine https://doi.org/10.1038/s41591-024-03025-3, published online 6 June 2024
In the version of the article initially published, in the key to Fig. 2b, the red diamond representing “Recurrence/NR” has been corrected to a green diamond to match the graph. This correction has been made to the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, R., Shah, P.H., Stewart, T.F. et al. Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Nat Med 30, 2377 (2024). https://doi.org/10.1038/s41591-024-03157-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-024-03157-6
